Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial

Joon Young Song, Won Suk Choi, Jung Yeon Heo, Jin Soo Lee, Dong Sik Jung, Shin-Woo Kim, Kyung-Hwa Park, Joong Sik Eom, Su Jin Jeong, Jacob Lee, Ki Tae Kwon, Hee Jung Choi, Jang Wook Sohn, Young Keun Kim, Ji Yun Noh, Woo Joo Kim, François Roman, Maria Angeles Ceregido, Francesca Solmi, Agathe Philippot, Alexandra C. Walls, Lauren Carter, David Veesler, Neil P. King, Hun Kim, Ji Hwa Ryu, Su Jeen Lee, Yong Wook Park, Ho Keun Park, Hee Jin Cheong

Open source

DOI: 10.1016/j.eclinm.2022.101569
Published: 2022-09
Container: eClinicalMedicine
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.eclinm.2022.101569,
  title = {Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial},
  author = {Joon Young Song and Won Suk Choi and Jung Yeon Heo and Jin Soo Lee and Dong Sik Jung and Shin-Woo Kim and Kyung-Hwa Park and Joong Sik Eom and Su Jin Jeong and Jacob Lee and Ki Tae Kwon and Hee Jung Choi and Jang Wook Sohn and Young Keun Kim and Ji Yun Noh and Woo Joo Kim and François Roman and Maria Angeles Ceregido and Francesca Solmi and Agathe Philippot and Alexandra C. Walls and Lauren Carter and David Veesler and Neil P. King and Hun Kim and Ji Hwa Ryu and Su Jeen Lee and Yong Wook Park and Ho Keun Park and Hee Jin Cheong},
  year = {2022},
  journal = {eClinicalMedicine},
  doi = {10.1016/j.eclinm.2022.101569},
  url = {https://doi.org/10.1016/j.eclinm.2022.101569}
}

RIS

TY  - JOUR
TI  - Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial
AU  - Joon Young Song
AU  - Won Suk Choi
AU  - Jung Yeon Heo
AU  - Jin Soo Lee
AU  - Dong Sik Jung
AU  - Shin-Woo Kim
AU  - Kyung-Hwa Park
AU  - Joong Sik Eom
AU  - Su Jin Jeong
AU  - Jacob Lee
AU  - Ki Tae Kwon
AU  - Hee Jung Choi
AU  - Jang Wook Sohn
AU  - Young Keun Kim
AU  - Ji Yun Noh
AU  - Woo Joo Kim
AU  - François Roman
AU  - Maria Angeles Ceregido
AU  - Francesca Solmi
AU  - Agathe Philippot
AU  - Alexandra C. Walls
AU  - Lauren Carter
AU  - David Veesler
AU  - Neil P. King
AU  - Hun Kim
AU  - Ji Hwa Ryu
AU  - Su Jeen Lee
AU  - Yong Wook Park
AU  - Ho Keun Park
AU  - Hee Jin Cheong
PY  - 2022
JO  - eClinicalMedicine
DO  - 10.1016/j.eclinm.2022.101569
UR  - https://doi.org/10.1016/j.eclinm.2022.101569
ER  -

APA

Song, J. Y., Choi, W. S., Heo, J. Y., Lee, J. S., Jung, D. S., Kim, S., Park, K., Eom, J. S., Jeong, S. J., Lee, J., Kwon, K. T., Choi, H. J., Sohn, J. W., Kim, Y. K., Noh, J. Y., Kim, W. J., Roman, F., Ceregido, M. A., Solmi, F., Philippot, A., Walls, A. C., Carter, L., Veesler, D., King, N. P., Kim, H., Ryu, J. H., Lee, S. J., Park, Y. W., Park, H. K., & Cheong, H. J. (2022). Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial. eClinicalMedicine. https://doi.org/10.1016/j.eclinm.2022.101569

Source records

crossref · retrieved 2026-09-26T11:32:33.236Z